Microbial/enzymatic synthesis of chiral drug intermediates
- 1 January 2000
- book chapter
- Published by Elsevier
- Vol. 47, 33-78
- https://doi.org/10.1016/s0065-2164(00)47001-2
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Chemoenzymatic Synthesis of (S)-(-)-Frontalin Using Bacterial Epoxide HydrolasesSynthesis, 1997
- BMS-187257, a potent, selective, and novel heterocyclic β3 adrenergic receptor agonistBioorganic & Medicinal Chemistry Letters, 1996
- Synthesis of a potential enzyme‐specific inhibitor of squalene synthaseRecueil des Travaux Chimiques des Pays-Bas, 1995
- Highly selective asymmetric hydrolysis of 2,2-disubstituted epoxides using lyophilized cells of Rhodococcus sp. NCIMB 11216Journal of the Chemical Society, Perkin Transactions 1, 1995
- Application of computer to monitoring and control of fermentation process: Microbial conversion of ML‐236B Na to pravastatinBiotechnology & Bioengineering, 1993
- Purification and characterization of cytochrome P‐450sca from Streptomyces carbophilusEuropean Journal of Biochemistry, 1989
- Total synthesis of a mycobactin: mycobactin S2Journal of the American Chemical Society, 1983
- A general method for the preparation of the D- or L-stereoisomers of 5-substituted hydantoins.Agricultural and Biological Chemistry, 1978
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967